Back

Impact of the type of acute coronary syndrome on the pharmocodynamic response to P2Y12 inhibitors in the acute and maintenance phase of therapy

31 August 2019 (11:36 - 11:45)
Organised by:
Congress Presentation Part of: New insights for acute coronary syndrome pharmacotherapy Thrombosis, Platelets, and Coagulation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Leslie Marisol Lugo Gavidia

CONSAM, Santiago de Queretaro (Mexico)

8 More presentations in this session

Presentation thumbnail
Revacept, an inhibitor of platelet adhesion in symptomatic carotid stenosis: Results from a phase II study
Assistant Professor K. Groschel (Mainz, DE)
Abstract
Presentation thumbnail
Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome and multivessel coronary artery disease: a post-hoc analysis of the TROPICAL-ACS trial
Assistant Professor K. Rizas (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Effects of Interleukin-1 blockade with Anakinra on cardiac function in ST-segment elevation acute myocardial infarction: results from the VCUART3 echocardiography study
Doctor A. Abbate (Charlottesville, US)
Abstract Slides Video
Presentation thumbnail
New possibilities of thrombolytic therapy in patients with STEMI according to a multicenter clinical study FRIDOM1.
Doctor E. Gerasimets (Moscow, RU)
Abstract Slides Video
Presentation thumbnail
Heart transplant recipients with cardiac allograft vasculopathy have increased platelet aggregation before and after low-dose aspirin therapy
Doctor K. Bjerre (Aarhus, DK)
Abstract Slides Video

Access the full session

Session thumbnail
New insights for acute coronary syndrome pharmacotherapy

The Event

Event poster

ESC Congress 2019

31 August 2019 11:36 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources